 Massimo Buvoli
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myosin Heavy Chains | 8 | 2024 | 192 | 1.410 |
Why?
| | Distal Myopathies | 3 | 2024 | 9 | 1.380 |
Why?
| | Proline | 3 | 2024 | 79 | 1.320 |
Why?
| | Amino Acid Substitution | 3 | 2024 | 307 | 0.860 |
Why?
| | Cardiac Myosins | 5 | 2024 | 30 | 0.830 |
Why?
| | Gene Transfer Techniques | 4 | 2007 | 170 | 0.620 |
Why?
| | Mutation | 4 | 2011 | 3958 | 0.410 |
Why?
| | Sarcomeres | 2 | 2015 | 96 | 0.390 |
Why?
| | Myocardium | 4 | 2021 | 1002 | 0.390 |
Why?
| | Exons | 4 | 2010 | 355 | 0.370 |
Why?
| | RNA, Transfer | 3 | 2003 | 138 | 0.370 |
Why?
| | Myocytes, Cardiac | 3 | 2021 | 526 | 0.340 |
Why?
| | RNA Splicing | 3 | 2007 | 269 | 0.320 |
Why?
| | Muscular Dystrophy, Animal | 2 | 2007 | 9 | 0.310 |
Why?
| | Adenoviridae | 3 | 2007 | 193 | 0.280 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2007 | 92 | 0.250 |
Why?
| | Cardiomyopathies | 3 | 2021 | 350 | 0.250 |
Why?
| | Codon, Terminator | 2 | 2002 | 25 | 0.230 |
Why?
| | Genetic Vectors | 2 | 2002 | 319 | 0.210 |
Why?
| | Computational Biology | 1 | 2008 | 644 | 0.210 |
Why?
| | Mice, Transgenic | 3 | 2024 | 2167 | 0.200 |
Why?
| | RNA, Messenger | 5 | 2021 | 2833 | 0.200 |
Why?
| | Mice | 11 | 2024 | 17787 | 0.200 |
Why?
| | Genomics | 1 | 2008 | 795 | 0.200 |
Why?
| | Mutation, Missense | 1 | 2024 | 341 | 0.190 |
Why?
| | Myosin Type II | 1 | 2021 | 17 | 0.180 |
Why?
| | Animals | 17 | 2024 | 36940 | 0.180 |
Why?
| | Muscle Contraction | 1 | 2024 | 424 | 0.180 |
Why?
| | Ventricular Myosins | 2 | 2012 | 35 | 0.170 |
Why?
| | Heart Ventricles | 2 | 2021 | 788 | 0.170 |
Why?
| | Suppression, Genetic | 1 | 2000 | 25 | 0.170 |
Why?
| | COS Cells | 3 | 2016 | 188 | 0.160 |
Why?
| | Myocardial Contraction | 1 | 2021 | 341 | 0.160 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2019 | 22 | 0.160 |
Why?
| | Myoblasts | 1 | 2019 | 84 | 0.150 |
Why?
| | Promoter Regions, Genetic | 2 | 2002 | 1250 | 0.150 |
Why?
| | MicroRNAs | 2 | 2019 | 692 | 0.150 |
Why?
| | Heart | 1 | 2003 | 655 | 0.150 |
Why?
| | Myosin Subfragments | 2 | 2015 | 22 | 0.140 |
Why?
| | Muscle, Skeletal | 3 | 2024 | 1724 | 0.140 |
Why?
| | Molecular Sequence Data | 9 | 2015 | 2900 | 0.140 |
Why?
| | Transcription, Genetic | 3 | 2002 | 1457 | 0.130 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 3 | 1993 | 8 | 0.130 |
Why?
| | Contracture | 1 | 2016 | 20 | 0.130 |
Why?
| | DNA | 5 | 2016 | 1459 | 0.130 |
Why?
| | Rats | 5 | 2021 | 5647 | 0.130 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2019 | 385 | 0.120 |
Why?
| | Ribonucleoproteins | 3 | 1993 | 105 | 0.120 |
Why?
| | Protein Structure, Secondary | 2 | 2015 | 374 | 0.110 |
Why?
| | RNA, Heterogeneous Nuclear | 2 | 1993 | 5 | 0.110 |
Why?
| | Cell Line | 4 | 2019 | 2847 | 0.110 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2607 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 2 | 2011 | 2486 | 0.110 |
Why?
| | Alternative Splicing | 2 | 2010 | 229 | 0.100 |
Why?
| | Genes | 2 | 1990 | 230 | 0.100 |
Why?
| | Transfection | 3 | 2012 | 945 | 0.100 |
Why?
| | Cell Differentiation | 2 | 2019 | 1991 | 0.100 |
Why?
| | Cells, Cultured | 4 | 2007 | 4193 | 0.100 |
Why?
| | Enhancer Elements, Genetic | 2 | 2007 | 190 | 0.090 |
Why?
| | Genes, Reporter | 2 | 2003 | 269 | 0.090 |
Why?
| | Base Sequence | 6 | 2007 | 2181 | 0.090 |
Why?
| | Amino Acids | 1 | 2015 | 497 | 0.090 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 38 | 0.090 |
Why?
| | Animals, Genetically Modified | 1 | 2011 | 240 | 0.090 |
Why?
| | Plasmids | 2 | 2003 | 363 | 0.080 |
Why?
| | Protein Structure, Tertiary | 2 | 2012 | 861 | 0.080 |
Why?
| | Introns | 1 | 2010 | 258 | 0.080 |
Why?
| | Amino Acid Sequence | 5 | 2015 | 2139 | 0.070 |
Why?
| | Protein Isoforms | 1 | 2010 | 404 | 0.070 |
Why?
| | Caenorhabditis elegans | 1 | 2011 | 306 | 0.070 |
Why?
| | Muscular Diseases | 1 | 2008 | 114 | 0.070 |
Why?
| | Dystrophin | 1 | 2007 | 35 | 0.070 |
Why?
| | Polylysine | 1 | 2007 | 17 | 0.070 |
Why?
| | DNA Mutational Analysis | 1 | 2008 | 399 | 0.070 |
Why?
| | Databases, Genetic | 1 | 2008 | 237 | 0.070 |
Why?
| | Humans | 15 | 2024 | 137585 | 0.060 |
Why?
| | Hypertrophy | 1 | 2007 | 133 | 0.060 |
Why?
| | Oligonucleotide Probes | 2 | 2000 | 51 | 0.060 |
Why?
| | Protein Conformation | 1 | 2008 | 934 | 0.060 |
Why?
| | Animals, Newborn | 1 | 2007 | 844 | 0.060 |
Why?
| | Blotting, Western | 2 | 2021 | 1226 | 0.050 |
Why?
| | Mutant Proteins | 2 | 2015 | 103 | 0.050 |
Why?
| | Male | 4 | 2024 | 67762 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2009 | 2426 | 0.050 |
Why?
| | Molecular Biology | 1 | 2003 | 59 | 0.050 |
Why?
| | Genetic Therapy | 2 | 2002 | 297 | 0.050 |
Why?
| | Oligodeoxyribonucleotides | 2 | 2000 | 143 | 0.050 |
Why?
| | Gene Targeting | 1 | 2002 | 81 | 0.050 |
Why?
| | Luciferases | 1 | 2002 | 150 | 0.050 |
Why?
| | Nucleic Acid Hybridization | 2 | 2000 | 190 | 0.050 |
Why?
| | Transgenes | 1 | 2002 | 180 | 0.040 |
Why?
| | RNA, Transfer, Ser | 1 | 2000 | 4 | 0.040 |
Why?
| | Female | 3 | 2024 | 73304 | 0.040 |
Why?
| | Cadaver | 1 | 2021 | 296 | 0.040 |
Why?
| | Blotting, Northern | 1 | 2000 | 201 | 0.040 |
Why?
| | Myogenin | 1 | 2019 | 16 | 0.040 |
Why?
| | RNA | 2 | 2021 | 921 | 0.040 |
Why?
| | Tongue | 1 | 2000 | 81 | 0.040 |
Why?
| | Mammals | 1 | 2021 | 283 | 0.040 |
Why?
| | Tropomyosin | 1 | 1998 | 14 | 0.040 |
Why?
| | Down-Regulation | 1 | 2019 | 657 | 0.030 |
Why?
| | Cardiovascular Diseases | 2 | 2002 | 2111 | 0.030 |
Why?
| | Back | 1 | 2016 | 11 | 0.030 |
Why?
| | Heterogeneous Nuclear Ribonucleoprotein A1 | 3 | 1993 | 5 | 0.030 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 3 | 1993 | 17 | 0.030 |
Why?
| | Neck | 1 | 2016 | 101 | 0.030 |
Why?
| | Repetitive Sequences, Amino Acid | 1 | 2015 | 17 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 293 | 0.030 |
Why?
| | Pliability | 1 | 2015 | 46 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2015 | 183 | 0.030 |
Why?
| | Protein Stability | 1 | 2015 | 176 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 5757 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2015 | 570 | 0.030 |
Why?
| | HeLa Cells | 2 | 1998 | 636 | 0.030 |
Why?
| | RNA-Binding Proteins | 2 | 1998 | 422 | 0.030 |
Why?
| | Molecular Dynamics Simulation | 1 | 2015 | 213 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4295 | 0.030 |
Why?
| | Models, Biological | 1 | 2000 | 1783 | 0.020 |
Why?
| | Electrochemistry | 1 | 2012 | 78 | 0.020 |
Why?
| | Scattering, Radiation | 1 | 2012 | 101 | 0.020 |
Why?
| | Surface Plasmon Resonance | 1 | 2012 | 87 | 0.020 |
Why?
| | Gene Expression | 1 | 1997 | 1502 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2012 | 375 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2012 | 192 | 0.020 |
Why?
| | SOXD Transcription Factors | 1 | 2010 | 5 | 0.020 |
Why?
| | Poly A | 1 | 1990 | 51 | 0.020 |
Why?
| | Codon, Nonsense | 1 | 2010 | 44 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 1990 | 164 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2012 | 665 | 0.020 |
Why?
| | Light | 1 | 2012 | 381 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2010 | 332 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2010 | 343 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1990 | 534 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2189 | 0.020 |
Why?
| | Phenotype | 1 | 2016 | 3196 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 1990 | 433 | 0.020 |
Why?
| | Escherichia coli | 1 | 1990 | 815 | 0.020 |
Why?
| | Zebrafish | 1 | 2010 | 499 | 0.010 |
Why?
| | Restriction Mapping | 2 | 1993 | 77 | 0.010 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2000 | 17 | 0.010 |
Why?
| | Binding Sites | 2 | 1993 | 1303 | 0.010 |
Why?
| | Mice, Inbred mdx | 1 | 1997 | 12 | 0.010 |
Why?
| | Nucleic Acid Conformation | 1 | 2000 | 728 | 0.010 |
Why?
| | Aged | 1 | 2016 | 23961 | 0.010 |
Why?
| | Adult | 1 | 2016 | 37929 | 0.010 |
Why?
| | Growth Substances | 1 | 1993 | 147 | 0.010 |
Why?
| | Culture Media | 1 | 1993 | 165 | 0.010 |
Why?
| | Cyclic AMP | 1 | 1993 | 234 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 1997 | 1050 | 0.010 |
Why?
| | Cell Division | 1 | 1993 | 794 | 0.010 |
Why?
| | Transcription Factors | 1 | 1993 | 1719 | 0.000 |
Why?
|
|
Buvoli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|